Pilots.jpg

PILOT RESEARCH PROJECTS

PILOT GRANT PROGRAM (PGP)

Investigator Development Core

The HEALTH Center for Addictions Research and Cancer Prevention is pursuing a bold research agenda to address the public health crises that health disparities inflict on our most vulnerable communities. With support from the National Institute on Minority Health and Health Disparities (NIMHD), this national center (Research Centers in Minority Institutions, RCMI) serves as an exemplar for community-engaged research. This research aims to accelerate discovery of novel prevention, early detection, diagnosis, and intervention strategies that can be disseminated and implemented directly into underserved communities. Moreover, mentorship and professional development activities are structured to develop the next generation of health-equity scientists capable of advancing data-driven and culturally-responsive breakthroughs in alcohol, tobacco, and other drug (ATOD) research and cancer prevention.

This short-term (1-year) funding opportunity will support 3-5 innovative pilot grants ($30,000 to $50,000) per year through 2 calls for applications (1 in the fall, 1 in the spring). Successful applications will propose to break new ground in health-equity science while successfully leveraging the data to transition into a developmentally appropriate NIH funding mechanism (e.g., K- and R-series).  

Important dates associated with the upcoming Request for Applications (RFA):

Letter of Intent (LOI) Due: January 3, 2023 @ 5:00 p.m.

Complete Application Due: February 3, 2023 @ 5:00 p.m.

Scientific Merit Review: March 24, 2023

Funding Decisions and NIMHD Approval: Between April 2023 - May 2023 

Earliest Anticipated Award Start Date: June 1, 2023

Download: RFA Guidelines

Download: Cover Page 

Please watch our 15-minute webinar to receive some background information regarding the HEALTH-RCMI’s Pilot Grant Program.

All questions regarding this RFA may be directed to Dr. Ezemenari M. Obasi (RCMI, PI), Dr. Anka Vujanovic (IDC Director), or HEALTH-RCMI Staff.

 

SPRING 2022 PILOT PROJECTS

A mobile intervention for Cannabis-related disparities among Black Cannabis Users: A pilot study 

Dr. Lorra Garey, Ph.D., Principal Investigator

Project Team: 

  • Brooke Kauffman, Ph.D., Co-Investigator

  • Michael J. Zvolensky, Ph.D., Co-Investigator

  • Michael Businelle, Ph.D., Co-Investigator

  • Julia Bucker, Ph.D., Co-Investigator

FALL 2021 PILOT PROJECTS

Proof of concept and feasibility in podcasting cervical cancer prevention for African American women

Dr. Chakema Carmack, Ph.D., Principal Investigator

The use of smoking cessation medications (NRT, varenicline) among populations with mental health issues and non-nicotine substance use disorders

Dr. Anastasia Rogova, Ph.D., Principal Investigator

 

Project Team:

  • Dr. Lorraine R. Reitzel, Ph.D., Co-Investigator

  • Dr. Isabel Martinez Leal, Ph.D., Co-Investigator

 

Interventions to improve adherence to oral endocrine therapies for prevention of new or recurrent breast cancer in African American women of low socioeconomic status

 

Dr. Meghana Trivedi, Ph.D., Pharm.D., Multiple Principal Investigator

Dr. Onyebuchi J. Ononogbu, Pharm.D., Multiple Principal Investigator

Dr. Susan Abughosh, Ph.D., Multiple Principal Investigator

Dr. Robert Shimko, Ph.D., Multiple Principal Investigator

Project Team:

  • Keith Houk, MFA, Co-Investigator

SPRING 2021 PILOT PROJECTS

Examining Health Disparities and Promoting Breast Cancer Awareness and Prevention in Syrian Refugee Women in the United States

 

Samina Salim, Ph.D., Principal Investigator

Project Team:

  • Johanna Bick, Ph.D., Co-Investigator

  • Mohan Chandra, Ph.D., Collaborator

  • Meghana Trivedi, Ph.D., Collaborator

  • Sausaun Abouharb, M.D., Collaborator

Learn more about Dr. Salim's research and her community outreach efforts. 

Exploring the provider and organization level barriers to Medication for Opioid Use Disorder (MOUD) treatment for Black Americans

 

Lauren R. Gilbert, Ph.D., Principal Investigator

 

Project Team:

  • Steven Starks, M.D., Co-Investigator

Learn more about Dr. Gilbert's research.